Literature DB >> 9065818

Gene deficiency of glutathione S-transferase mu isoform associated with susceptibility to lung cancer in a Chinese population.

G F Sun1, N Shimojo, J B Pi, S Lee, Y Kumagai.   

Abstract

Increased lung cancer risk associated with genetic polymorphism of glutathione S-transferase (GST, EC 2.5.1.18) isozyme mu was examined in a Chinese population. A significantly higher proportion in lung cancer patients showed GST mu deficiency compared with control group (71.0% vs. 51.1%, P < 0.005). Although the susceptibility to lung cancer showing gene deletion for GST mu isoform in non-smoking group is not significantly different from that in smoking group, a great number of individuals with gene deletion was found among cancer patients who are less than 50 years old. The pathology of lung tumors related to that lack of class mu isoform which occurred most frequently in patients with small cell carcinomas. Thus, present data further support that sensitivity to chemical toxins and pulmonary carcinogens may be affected by GST mu isoform polymorphism.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9065818     DOI: 10.1016/s0304-3835(97)04612-0

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  12 in total

1.  Association between GSTM1, GSTT1, and GSTP1 polymorphisms and lung cancer risk in a Turkish population.

Authors:  Ahmet O Ada; Semih C Kunak; Figen Hancer; Emre Soydas; Sibel Alpar; Meral Gulhan; Mumtaz Iscan
Journal:  Mol Biol Rep       Date:  2011-12-30       Impact factor: 2.316

2.  Assessment of cumulative evidence for the association between glutathione S-transferase polymorphisms and lung cancer: application of the Venice interim guidelines.

Authors:  Scott M Langevin; John P A Ioannidis; Paolo Vineis; Emanuela Taioli
Journal:  Pharmacogenet Genomics       Date:  2010-10       Impact factor: 2.089

3.  A comparison of glutathione S-transferase mutant frequencies in healthy Han and Uygur Chinese.

Authors:  Shi-Long Zhong; Shufeng Zhou; Min Huang
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2005 Jul-Sep       Impact factor: 2.441

Review 4.  Systematic review with meta-analysis of the epidemiological evidence in the 1900s relating smoking to lung cancer.

Authors:  Peter N Lee; Barbara A Forey; Katharine J Coombs
Journal:  BMC Cancer       Date:  2012-09-03       Impact factor: 4.430

5.  The interaction between smoking and GSTM1 variant on lung cancer in the Chinese population.

Authors:  Yanan Zhang; Chibo Liu
Journal:  Tumour Biol       Date:  2012-10-23

6.  GSTM1 polymorphism and lung cancer risk among East Asian populations: a meta-analysis.

Authors:  Yan Zhao; Junjie Zeng; Yanxi Zhang; Su Lu; Erjiang Zhao; Ziming Huang; Weiquan Lu
Journal:  Tumour Biol       Date:  2014-04-01

7.  Analysis of GSTM1 and GSTT1 polymorphisms in circulating plasma DNA of lung cancer patients.

Authors:  Rosa Estela Caseira Cabral; Adriano Caldeira-de-Araujo; Januario Bispo Cabral-Neto; Maria da Gloria Costa Carvalho
Journal:  Mol Cell Biochem       Date:  2010-01-05       Impact factor: 3.396

8.  Gene polymorphisms of biotransforming enzymes (GSTs) and their association with lung cancer in the Slovakian population.

Authors:  T Matakova; M Sivonova; E Halasova; D Mistuna; A Dzian; P Berzinec; L Letkova; D Dobrota
Journal:  Eur J Med Res       Date:  2009-12-07       Impact factor: 2.175

9.  Five glutathione s-transferase gene variants in 23,452 cases of lung cancer and 30,397 controls: meta-analysis of 130 studies.

Authors:  Zheng Ye; Honglin Song; Julian P T Higgins; Paul Pharoah; John Danesh
Journal:  PLoS Med       Date:  2006-03-07       Impact factor: 11.069

10.  The role of GSTM1 gene polymorphisms in lung cancer development in Turkish population.

Authors:  Adalet Demir; Sedat Altin; Davut Pehlivan; Mulahim Demir; Fatih Yakar; Ekrem Cengiz Seyhan; Seyyit Ibrahim Dincer
Journal:  J Carcinog       Date:  2007-09-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.